LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Neoleukin Therapeutics and Millions of Other Companies

Sign up for full access to Neoleukin Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Merger Expansion Neurogene Inc., following a merger with Neoleukin Therapeutics, has expanded its facilities to Houston, Texas, creating opportunities for partnerships and collaborations in the gene therapy manufacturing sector.

Talent Acquisition Strategy Neurogene Inc.'s strategic hiring of key personnel like Donna Cochener as Senior Vice President and Julie Jordan as Chief Medical Officer signals growth and innovation, presenting an opportunity for synergistic partnerships in the biotechnology research space.

Partnership Development Neurogene Inc.'s partnership with the University of Rochester reflects a commitment to collaboration and knowledge sharing, offering avenues for joint research projects and potential educational partnerships.

Product Expansion The launch of NGN-401 for Rett syndrome showcases Neurogene Inc.'s commitment to expanding its product pipeline, presenting an opportunity for pharmaceutical sales representatives to explore new therapeutic offerings.

Financial Support Neurogene Inc.'s successful private financing round of $95 million highlights investor confidence and financial stability, potentially creating opportunities for investment partnerships or service agreements within the biotechnology industry.

Similar companies to Neoleukin Therapeutics

✕

Access Insights for Neoleukin Therapeutics and Millions of Other Companies

Sign up for full access to Neoleukin Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Neoleukin Therapeutics Tech Stack

Neoleukin Therapeutics uses 8 technology products and services including Facebook Pixel, SAS, NetSuite ERP, and more. Explore Neoleukin Therapeutics's tech stack below.

  • Facebook Pixel
    Analytics
  • SAS
    Business Intelligence
  • NetSuite ERP
    Enterprise Resource Planning
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • Twitter
    Widgets
  • Facebook
    Widgets

Media & News

Neoleukin Therapeutics's Email Address Formats

Neoleukin Therapeutics uses at least 2 format(s):
Neoleukin Therapeutics Email FormatsExamplePercentage
FLast@neoleukin.comJDoe@neoleukin.com
92%
Last@neoleukin.comDoe@neoleukin.com
5%
First.Last@neoleukin.comJohn.Doe@neoleukin.com
3%
First.Last@neurogene.comJohn.Doe@neurogene.com
96%
FirstMiddle.Last@neurogene.comJohnMichael.Doe@neurogene.com
1%
Last.First@neurogene.comDoe.John@neurogene.com
2%
First.Middle@neurogene.comJohn.Michael@neurogene.com
1%

Frequently Asked Questions

Where is Neoleukin Therapeutics's headquarters located?

Minus sign iconPlus sign iconNeoleukin Therapeutics's main headquarters is located at 1616 Eastlake Ave E 360 Seattle, Washington 98102 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Neoleukin Therapeutics's stock symbol?

Minus sign iconPlus sign iconNeoleukin Therapeutics is a publicly traded company; the company's stock symbol is NGNE.

What is Neoleukin Therapeutics's official website and social media links?

Minus sign iconPlus sign iconNeoleukin Therapeutics's official website is neurogene.com and has social profiles on LinkedIn.

How much revenue does Neoleukin Therapeutics generate?

Minus sign iconPlus sign icon As of May 2024, Neoleukin Therapeutics's annual revenue reached $15M.

What is Neoleukin Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconNeoleukin Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neoleukin Therapeutics have currently?

Minus sign iconPlus sign iconAs of May 2024, Neoleukin Therapeutics has approximately 51 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: B. A.Chief Medical Officer: P. P.Chief Operating Officer And Chief Financial Officer: E. L.. Explore Neoleukin Therapeutics's employee directory with LeadIQ.

What industry does Neoleukin Therapeutics belong to?

Minus sign iconPlus sign iconNeoleukin Therapeutics operates in the Biotechnology Research industry.

What technology does Neoleukin Therapeutics use?

Minus sign iconPlus sign iconNeoleukin Therapeutics's tech stack includes Facebook PixelSASNetSuite ERPFont AwesomejQueryUbuntuTwitterFacebook.

What is Neoleukin Therapeutics's email format?

Minus sign iconPlus sign iconNeoleukin Therapeutics's email format typically follows the pattern of . Find more Neoleukin Therapeutics email formats with LeadIQ.

How much funding has Neoleukin Therapeutics raised to date?

Minus sign iconPlus sign icon As of May 2024, Neoleukin Therapeutics has raised $71M in funding. The last funding round occurred on Jul 02, 2020 for $71M.

When was Neoleukin Therapeutics founded?

Minus sign iconPlus sign iconNeoleukin Therapeutics was founded in 2019.
Neoleukin Therapeutics

Neoleukin Therapeutics

Biotechnology ResearchWashington, United States51-200 Employees

Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We historically created next generation immunotherapies using breakthrough de novo protein design technology. 

In December 2023, the previously announced merger between Neurogene Inc and Neoleukin Therapeutics (NGNE) was completed. Neurogene is a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases.

For more information about the Neurogene, please visit www.neurogene.com, @NeurogeneInc on X (formerly Twitter) or @Neurogene Inc on LinkedIn.

✕

Access Insights for Neoleukin Therapeutics and Millions of Other Companies

Sign up for full access to Neoleukin Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
1616 Eastlake Ave E 360 Seattle, Washington 98102 US
Website
neurogene.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NGNE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $71M

    Neoleukin Therapeutics has raised a total of $71M of funding over 3 rounds. Their latest funding round was raised on Jul 02, 2020 in the amount of $71M.

  • $10M$50M

    Neoleukin Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $71M

    Neoleukin Therapeutics has raised a total of $71M of funding over 3 rounds. Their latest funding round was raised on Jul 02, 2020 in the amount of $71M.

  • $10M$50M

    Neoleukin Therapeutics's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Neoleukin Therapeutics and Millions of Other Companies

Sign up for full access to Neoleukin Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.